Stock listing

RAPP Stock Price, News, Filings & Events — Rapport Therapeutics, Inc.

Selected listing: RAPP · NASDAQ · USD · US

This page tracks Rapport Therapeutics, Inc.'s RAPP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RAPP:NASDAQ. RAPP:NASDAQ is the stock-level entry point for investors researching Rapport Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rapport Therapeutics, Inc. (Ticker: RAPP) is a public company operating in the American market, with a market capitalization of approximately $2.04 billion. The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its dedicated public company page.

RAPP:NASDAQUSDUSUpdated September 11, 2026
Rapport Therapeutics, Inc. logo
Ticker
RAPP:NASDAQ
Asset type
Stock
Market cap
$2.09B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Rapport Therapeutics, Inc. RAPP:NASDAQ stock context

This page tracks Rapport Therapeutics, Inc.'s RAPP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RAPP:NASDAQ. RAPP:NASDAQ is the stock-level entry point for investors researching Rapport Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rapport Therapeutics, Inc. (Ticker: RAPP) is a public company operating in the American market, with a market capitalization of approximately $2.04 billion. The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its dedicated public company page.

Latest news from Rapport Therapeutics, Inc.

All Rapport Therapeutics, Inc. news →

Research Rapport Therapeutics, Inc.

Alternate listings